2017-2018 OSCC Executive

Nathalie Lepage


Nathalie Lepage, PhD, FCACB, FCCMG
Children’s Hospital of Eastern Ontario

Dr Lepage is a full professor in the department of Pathology and Laboratory Medicine at the University of Ottawa, Canada.  She is the Head of the Biochemical Genetics and Prenatal Screening Laboratory at the Children's Hospital of Eastern Ontario in Ottawa, Canada, the laboratory director for the Hawkesbury General Hospital, and a laboratory consultant for clinical Biochemistry for the teaching Montfort Hospital, both located in Eastern Ontario, Canada.  She is a fellow from the Canadian Academy of Clinical Biochemistry (CACB) and a fellow from the Canadian College of Medical Geneticists.  

Dr Lepage has also served as a leader (president and/or chair) of several provincial and national professional associations, including the CACB and the Ontario Society of Clinical Chemists. She has received the CACB Award for Outstanding Service to the profession of Clinical Biochemistry and the Mentor of the Month Award from the AACC.

Current areas of clinical and research interests are in pediatric reference intervals, in prenatal screening for chromosomal abnormalities and neural tube defects, and in laboratory management. 

baillon cynthia 150x200

Past President

Cynthia M. Balion, PhD, FCACB
St. Joseph’s Hospital

Dr. Cynthia Balion serves as Associate Professor of Pathology and Molecular Medicine, McMaster University. Dr. Balion is also a Clinical Biochemist for the Hamilton Regional Laboratory Medicine Program (HRLMP) and co-investigator for the Canadian Longitudinal Study on Aging (CLSA) where she serves as a Director of the Biorepository and Bioanalysis Centre. She has been Member of Technical Advisory Board at ChroMedX Corp. since October 2014. 

Ronald Booth


Ronald Booth, PhD, FCACB
The Ottawa Hospital

Dr. Booth completed his BSc in Biochemistry (1994) and MSc in Biochemistry and Biotechnology (1996) at Carleton University. He then moved to the Loeb Research Institute at the University of Ottawa where he completed a PhD in molecular biology (2002). Following his research training, he began his training in Clinical Biochemistry and received a Diploma in Clinical Chemistry (DCC) through the University of Toronto.  Dr. Booth is certified as a specialist in Clinical Chemistry and a fellow of the Canadian Academy of Clinical Biochemists.  He is currently a Clinical Biochemist at The Ottawa Hospital, Division of Biochemistry where he directs the Immunology Section of the EORLA regional laboratory. He is an Assistant Professor in the Department of Pathology and Laboratory Medicine at the University of Ottawa and a Clinical Investigator at the Ottawa Hospital Research Institute (OHRI).  Dr. Booth is also the Medical Director of the Cornwall Community Hospital diagnostic laboratory.

Dr. Booth’s research interests include diagnostic immunology and clinical utility of diagnostic testing.  He has co-authored textbooks on tumour markers and utility of pharmacogenetic testing and a number of systematic reviews of diagnostic test usage.

In 2009, Dr. Booth received the Donald J. Campbell Award for Outstanding Contribution to Clinical Chemistry from the Alberta Society of Clinical Chemistry. He is currently a member of the Endocrinology & Immunology Committee of the OMA’s Quality Management Program for Laboratory Services (IQMH), and a previous Specialist Member of the Canadian Agency for Drugs and Technologies in Health (CADTH), Health Technology Expert Review Panel (HTERP).

Kika Veljkovic


Kika Veljkovic, PhD, FCACB

Dr. Veljkovic is a graduate of the McMaster Postdoctoral Training Program in Clinical Biochemistry and a fellow of the Canadian Academy of Clinical Biochemistry. Dr. Veljkovic earned her MD from University of Belgrade, Serbia, and her PhD in hemostasis, thrombosis and vascular disease from McMaster University. She has published over 20 scientific papers and conference abstracts, including first-author papers in Blood and Clinical Biochemistry, and has presented at national and international conferences. Dr. Veljkovic has received several awards for research excellence, including major funding from Canadian Institutes of Health Research and Heart and Stroke Foundation of Canada, and awards from The Canadian Society of Clinical Chemists and American Association for Clinical Chemistry.

Dr. Veljkovic is a clinical biochemist at LifeLabs. Her daily work is focused on routine biochemistry and immunoassays, and she is involved in multiple projects, including immunoassay platform upgrades. In addition, Dr. Veljkovic is the Laboratory Director for the LifeLabs Hamilton site.

Dr. Veljkovic is an Assistant Clinical Professor (Adjunct) in the McMaster University Faculty of Health Sciences, Department of Pathology and Molecular Medicine.

In addition to the OSCC Secretary-Treasurer role, Dr. Veljkovic’s professional engagement includes membership in the Institute for Quality Management in Healthcare  Endocrinology and Immunology Scientific Committee.

Dana Bailey


Dana Bailey, PhD, FCACB

Dana Bailey is a fellow of the Canadian Academy of Clinical Biochemistry and the Laboratory Director for Dynacare at the London, Ontario site. She joined Dynacare in August 2013 and is responsible for overseeing the core laboratory. She completed both an MSc in Microbiology and PhD in Biochemistry at McGill University. During this time, she received a number of awards including the Vanier Canada Graduate Scholarship. Following, she completed a Postdoctoral fellowship in Clinical Chemistry at the University of Toronto, where she was awarded the Alan Pollard Postdoctoral Clinical Chemistry Award. Her research interests bridge clinical and quality concepts and include cardiovascular disease, development of reference intervals, and application of quality metrics to the clinical laboratory.

bottos joseph 150x200


Joseph Bottos
Beckman Coulter Canada

For over 35 years Joe Bottos has been involved in the field of medical laboratory technology and clinical biochemistry. He is a graduate of biochemistry at the University of Guelph and the Medical Laboratory Technology program at Mohawk College, Hamilton. Employed history includes, technical positions within veterinary biologics manufacturing, medical technologist in large teaching centers as well as community hospitals, autopsy assistant and has free-lanced as a scientific/medical illustrator with drawings published in “Grants Atlas of Human Anatomy". Currently he has been employed with Beckman Coulter Canada for over 25 years and is the National Product Manager for the chemistry and immunochemistry product lines.

lin daniel 150x200


Dan Lin, PhD, FCACB
The Ottawa Hospital

Dr. Dan Lin obtained his PhD in the Department of Molecular and Medical Genetics at the University of Toronto. His post-doctoral fellowship in Clinical Chemistry was completed at the University of Toronto. He is certified as a specialist in Clinical Chemistry and is a fellow of the Canadian Academy of Clinical Biochemistry (FCACB). His publications include more than 18 scientific papers in the fields of clinical biochemistry, cancer drug discovery and cellular signaling. Currently, Dr. Lin is a clinical biochemist at The Ottawa Hospital (TOH), Division of Biochemistry. At TOH, he provides oversight in porphyria testing and for biogenic amines. He is an Assistant Professor in the Department of Pathology and Laboratory Medicine at the University of Ottawa.

arnoldo saranya 150x200

Chair, Professional Affairs

Saranya Kittanakom-Arnoldo, PhD, FCACB
William Osler Health System

Dr. Arnoldo received her PhD degree from Mahidol University, Thailand and then post-doctoral training in Clinical Biochemistry from McMaster University, Hamilton, ON. She has more than 25 scientific publications and 19 poster presentations to her credit. She is currently a Clinical Biochemist at the London Health Sciences Centre, an Assistant Professor at the department of Pathology and Laboratory Medicine, Western University, and a fellow of the Canadian Academy of Clinical Biochemistry. At LHSC, she provides oversight of the core chemistry laboratory and point of care testing as well as evaluation and validation of new test methodologies.

OSCC By-Laws

Click here to view the By-Laws of the OSCC as approved on 4 Nov 2010.

Click here to view the past executive of OSCC (1969 to now)